PALVELLA THERAPEUTICS, INC. (PVLA) › Capital ExpendituresPALVELLA THERAPEUTICS, INC. (PVLA) — Capital ExpendituresAnnual figures by fiscal year, from SEC filings.2013: $49.5K2014: $267.4K2015: $620.7K2016: $560.0K2017: $1.95M2018: $1.70M2019: $2.46M2020: $2.73M2021: $949.0K2022: $1.04M2023: $171.0K$171.0K2013Capital Expenditures (USD)2023Fiscal YearCapital ExpendituresChange YoY2023$171.0K-83.6%2022$1.04M+9.7%2021$949.0K-65.2%2020$2.73M+10.7%2019$2.46M+45.0%2018$1.70M-12.9%2017$1.95M+248.2%2016$560.0K-9.8%2015$620.7K+132.1%2014$267.4K+440.5%2013$49.5K—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowShares OutstandingDividends Per Share